Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.232EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.269EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.234EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
V.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.149EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.413EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.41 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.142EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.166EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.11 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Z.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
V.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.131EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.235EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.90 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used